Genetic Technologies Ltd
OTC Pink - Current Information:GNTLF

  • LAST PRICE
    0.0007
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.0000 / 0.0007
  • Day Range
    ---
  • 52 Week Range
    0.0700
    ---
    6.3400
  • Volume
    ---

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Apr 22, 2024

      Show headlines and story abstract

    • 3:00PM ET on Monday Apr 22, 2024 by Dow Jones
      Companies Mentioned: GENE

      Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering

      MELBOURNE, Australia, April 23, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, "Company", "GTG", or "Genetic Technologies"), a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, today announces the closing of its previously announced registered offering for the purchase and sale of 1,000,000 American Depositary Shares ("ADSs") (or ADS equivalents in lieu thereof), each representing thirty (30) ordinary shares of the Company, at an offering price of US$2.00 per ADS.

    • 3:00PM ET on Monday Apr 22, 2024 by Dow Jones
      Companies Mentioned: GENE

      Genetic Technologies Announces Closing of US$2 Million Registered Direct Offering

      MELBOURNE, Australia, April 23, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, "Company", "GTG", or "Genetic Technologies"), a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, today announces the closing of its previously announced registered offering for the purchase and sale of 1,000,000 American Depositary Shares ("ADSs") (or ADS equivalents in lieu thereof), each representing thirty (30) ordinary shares of the Company, at an offering price of US$2.00 per ADS.

  • Apr 18, 2024

      Show headlines and story abstract

    • 2:47PM ET on Thursday Apr 18, 2024 by MT Newswires
      Companies Mentioned: GENE, WISA, LAC
      02:47 PM EDT, 04/18/2024 (MT Newswires) -- WiSA Technologies (WISA) shares fell more than 28% after the company struck a $750,000 securities sale deal. More than 14.5 million shares traded intraday compared with a daily average of about 4.54 million...

    • 1:01PM ET on Thursday Apr 18, 2024 by MT Newswires
      Companies Mentioned: GENE
      01:01 PM EDT, 04/18/2024 (MT Newswires) -- Genetic Technologies (GENE) said Thursday it agreed to sell 1 million American depositary shares at $2 each in a registered direct offering and unregistered warrants to purchase up to 1 million ADSs in a pr...

    • 12:17PM ET on Thursday Apr 18, 2024 by Dow Jones
      Companies Mentioned: GENE

      Genetic Technologies Announces $2 Million Registered Direct Offering

      MELBOURNE, Australia, April 19, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX:GTG; NASDAQ:GENE, "Company", "GTG", or "Genetic Technologies"), a global leader in guideline-driven genomics-based tests in health, wellness and serious diseases, today announced that it has entered into a definitive agreement for the purchase and sale in a registered direct offering of 1,000,000 American Depositary Shares ("ADSs") (or ADS equivalents in lieu thereof), each representing thirty (30) ordinary shares of the Company, at a purchase price of $2.00 per ADS. In addition, in a concurrent private placement, the Company will issue unregistered warrants ("Warrants") to purchase up to 1,000,000 ADSs. The Warrants will have an exercise price of $2.00 per ADS, will be exercisable upon issuance, and will expire five years following issuance. The closing of the offering is expected to occur on or about April 22, 2024, subject to the satisfaction of customary closing conditions.

Peers Headlines

No documents available